These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37542678)

  • 21. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between Adipose Tissue and Psoriasis, with or without Arthritis.
    Toussirot E; Aubin F; Dumoulin G
    Front Immunol; 2014; 5():368. PubMed ID: 25161652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
    Eickstaedt JB; Killpack L; Tung J; Davis D; Hand JL; Tollefson MM
    Pediatr Dermatol; 2017 May; 34(3):253-260. PubMed ID: 28211161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
    Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
    Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing.
    Su YJ
    Clin Rheumatol; 2020 Dec; 39(12):3677-3684. PubMed ID: 32468320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
    Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study.
    Scrivo R; Gerardi MC; Rutigliano I; Sessa P; Mipatrini D; Stricchiola GMG; Pacella E; Altobelli A; Castellani C; Alessandri C; Ceccarelli F; Di Franco M; Priori R; Riccieri V; Sili Scavalli A; Spinelli FR; La Torre G; Conti F; Valesini G
    Clin Rheumatol; 2018 Sep; 37(9):2573-2577. PubMed ID: 29732494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
    Montaudié H; Albert-Sabonnadière C; Acquacalda E; Fontas E; Danré A; Roux C; Ortonne JP; Lacour JP; Euller-Ziegler L; Passeron T
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1186-91. PubMed ID: 23981008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressants and the Risk of Psoriasis Induction: A Case-Control Study.
    Sadatmadani SF; Siadat AH; Iraji F; Alsahebfosoul F
    Adv Biomed Res; 2023; 12():16. PubMed ID: 36926437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis.
    Truong B; Rich-Garg N; Ehst BD; Deodhar AA; Ku JH; Vakil-Gilani K; Danve A; Blauvelt A
    Clin Cosmet Investig Dermatol; 2015; 8():563-9. PubMed ID: 26622188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 diabetes and psoriasis: links and risks.
    Holm JG; Thomsen SF
    Psoriasis (Auckl); 2019; 9():1-6. PubMed ID: 30697518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study.
    Goyal A; Dey AK; Chaturvedi A; Elnabawi YA; Aberra TM; Chung JH; Belur AD; Groenendyk JW; Lerman JB; Rivers JP; Rodante JA; Harrington CL; Varghese NJ; Sanda GE; Baumer Y; Sorokin AV; Teague HL; Genovese LD; Natarajan B; Joshi AA; Playford MP; Bluemke DA; Chen MY; Alavi A; Pitman RK; Powell-Wiley TM; Tawakol A; Gelfand JM; Mehta NN
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):465-477. PubMed ID: 30448131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
    Kristensen LE; Strober B; Poddubnyy D; Leung YY; Jo H; Kwok K; Vranic I; Fleishaker DL; Fallon L; Yndestad A; Gladman DD
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149965. PubMed ID: 36777695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA).
    Li SS; Du N; He SH; Liang X; Li TF
    Rheumatol Ther; 2022 Aug; 9(4):1079-1090. PubMed ID: 35579829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.
    Machado PM; Schäfer M; Mahil SK; Liew J; Gossec L; Dand N; Pfeil A; Strangfeld A; Regierer AC; Fautrel B; Alonso CG; Saad CGS; Griffiths CEM; Lomater C; Miceli-Richard C; Wendling D; Alpizar Rodriguez D; Wiek D; Mateus EF; Sirotich E; Soriano ER; Ribeiro FM; Omura F; Rajão Martins F; Santos H; Dau J; Barker JN; Hausmann J; Hyrich KL; Gensler L; Silva L; Jacobsohn L; Carmona L; Pinheiro MM; Zelaya MD; Severina MLÁ; Yates M; Dubreuil M; Gore-Massy M; Romeo N; Haroon N; Sufka P; Grainger R; Hasseli R; Lawson-Tovey S; Bhana S; Pham T; Olofsson T; Bautista-Molano W; Wallace ZS; Yiu ZZN; Yazdany J; Robinson PC; Smith CH
    Ann Rheum Dis; 2023 May; 82(5):698-709. PubMed ID: 36787993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of chronic urticaria relative to psoriasis in five European countries.
    Balp MM; Khalil S; Tian H; Gabriel S; Vietri J; Zuberbier T
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):282-290. PubMed ID: 28898460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive Process of Psoriasis and Its Comorbidities: From Epidemiology to Genetics.
    Gao J; Shen X; Ko R; Huang C; Shen C
    Front Genet; 2021; 12():735124. PubMed ID: 34899832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin manifestations in spondyloarthritis.
    Meier K; Schloegl A; Poddubnyy D; Ghoreschi K
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20975915. PubMed ID: 33343725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis.
    Armstrong A; Xia Q; John AR; Patel V; Seigel L
    Dermatol Ther (Heidelb); 2022 Sep; 12(9):2087-2103. PubMed ID: 35947341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.